MODELING FUNCTIONAL DECLINE OVER TIME IN SPORADIC INCLUSION BODY MYOSITIS

被引：15

作者：

Alfano, Lindsay N. ^{[1
]}

Yin, Han ^{[2
]}

Dvorchik, Igor ^{[2
]}

Maus, Elizabeth G. ^{[1
]}

Flanigan, Kevin M. ^{[1
]}

Mendell, Jerry R. ^{[1
]}

Lowes, Linda P. ^{[1
]}

机构：

[1] Nationwide Childrens Hosp, Ctr Gene Therapy, Res Inst, 700 Childrens Dr,Room AB1042, Columbus, OH 43205 USA

[2] Nationwide Childrens Hosp Biostat Core, Res Inst, Columbus, OH USA

来源：

MUSCLE & NERVE | 2017年 / 55卷 / 04期

关键词：

disease progression; function; natural history; logistic model; sporadic inclusion body myositis; DISEASE PROGRESSION; STRENGTH; THERAPY;

D O I：

10.1002/mus.25373

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Introduction: The ability to individualize recommendations or expectations of disease progression based on a patient's unique characteristics has merit for use in sporadic inclusion body myositis (sIBM). Methods: Fifty-five subjects with sIBM completed a battery of strength and functional outcomes at 2 study visits. These were used to develop mathematical models of disease progression in patients with sIBM for use in clinical and research settings. Results: The 6-minute walk test (6MWT) distance declined by an average of 27.5 meters (12%) per year. Significant factors that predict 6MWT were knee extension and plantarflexion strength and body weight, whereas the ability to stand from a chair was impacted by elbow extension strength. Stepping up on a curb was influenced by the patient's age at diagnosis and by knee extension. Statistical models to predict functional decline in sIBM were developed. Conclusion: Statistical models help explain the complex factors that influence decreased walking ability and other functional activities in sIBM.

引用

页码：526 / 531

页数：6

共 19 条

[11] National Institutes of Health, EFF SAF BIM BYM338 5
[12] Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis
Needham, Merrilee
Corbett, Alastair
Day, Timothy
Christiansen, Frank
Fabian, Vicki
Mastaglia, Frank L.
[J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2008, 15 (12) : 1350 - 1353
[13] Disease progression in sporadic inclusion body myositis: Observations in 78 patients
Peng, A
Koffman, BM
Malley, JD
Dalakas, MC
[J]. NEUROLOGY, 2000, 55 (02) : 296 - 298
[14] INHIBITION OF MYOSTATIN WITH EMPHASIS ON FOLLISTATIN AS A THERAPY FOR MUSCLE DISEASE
Rodino-Klapac, Louise R.
Haidet, Amanda M.
Kota, Janaiah
Handy, Chalonda
Kaspar, Brian K.
Mendell, Jerry R.
[J]. MUSCLE & NERVE, 2009, 39 (03) : 283 - 296
[15] A prospective natural history study of inclusion body myositis: Implications for clinical trials
Rose, MR
McDermott, MP
Thornton, CA
Palenski, C
Martens, WB
Griggs, RC
[J]. NEUROLOGY, 2001, 57 (03) : 548 - 550
[16] Machine learning algorithms to classify spinal muscular atrophy subtypes
Srivastava, Tuhin
Darras, Basil T.
Wu, Jim S.
Rutkove, Seward B.
[J]. NEUROLOGY, 2012, 79 (04) : 358 - 364
[17] Module modified acute physiology and chronic health evaluation II: predicting the mortality of neuro-critical disease
Su, Yingying
Wang, Miao
Liu, Yifei
Ye, Hong
Gao, Daiquan
Chen, Weibi
Zhang, Yunzhou
Zhang, Yan
[J]. NEUROLOGICAL RESEARCH, 2014, 36 (12) : 1099 - 1105
[18] Inclusion body myositis
Tawil, R
Griggs, RC
[J]. CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (06) : 653 - 657
[19] Tests of neuromuscular function are associated with fractures in patients with chronic kidney disease
West, Sarah L.
Jamal, Sophie A.
Lok, Charmaine E.
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (06) : 2384 - 2388

← 1 2 →